Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
Go back to Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit| (NASDAQ: BLTE) | Delayed: 168.67 -6.68 (3.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $175.35 | 52 Week High | $ | |||
| Open | $175.50 | 52 Week Low | $ | |||
| Day High | $175.50 | P/E | N/A | |||
| Day Low | $166.60 | EPS | $ | |||
| Volume | 153,821 | |||||

